Read our latest news!

Posted on May 6, 20215/6/21

EVERSANA advances commercialization readiness as Humanigen announces publication of phase 3 randomized double-blind placebo-controlled study demonstrating the efficacy and safety of lenzilumab™ in newly hospitalized COVID-19 patients

EVERSANA
Posted on May 6, 20215/6/21

EVERSANA™ strengthens global market access and pricing leadership in European expansion

Posted on April 6, 20214/6/21

EVERSANA Commercialization Executive Krista Pinto Named 2021 MM+M Hall of Femme Honoree

Posted on March 23, 20213/23/21

Eyenovia and EVERSANA Announce Partnership to Support the Potential Launch and Commercialization of MydCombi for Mydriasis

EVERSANA
Posted on February 25, 20212/25/21

EVERSANA Launches Chronic Disease Real-World Data Solution Covering More Than 80 Million Deidentified Patients to Drive Regulatory-Grade Clinical Research and Improve Patient Outcomes

Posted on February 1, 20212/1/21

Iterum Therapeutics Announces Collaboration with EVERSANA to Support Oral Sulopenem Launch

Posted on January 10, 20211/10/21

Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19

Posted on December 17, 202012/17/20

EVERSANA and Experic announce strategic partnership to optimize end-to-end contract manufacturing and commercialization services for life sciences industry

Posted on December 3, 202012/3/20

EVERSANA and ArisGlobal announce strategic partnership to transform drug safety automation and advance integrated compliance models

Posted on November 30, 202011/30/20

MacroGenics and EVERSANA Announce Agreement to Support the Potential Launch and Commercialization of Margetuximab

Discover EVERSANA

  • Resource Center

    We’re driven by a diverse team of experts who understand the challenges facing today's industry.

    Learn More
  • Experts

    We’re driven by a diverse team of experts who understand the challenges facing today's industry.

    Experts